Cellebrite’s (CLBT) Compounding Track Record Demands Enterprise Software Re-Rating
Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Cellebrite Di Ltd. (CLBT)
Market is closed
Sector: Services-Prepackaged Software
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Voss Capital Travis Cocke | 11,441,874 | $167,051,360 | +19% | 7.76% |
| 2. | Pertento Partners Ian Trundle | 8,004,867 | $116,871,058 | +21% | 6.3% |
| 3. | Nine Ten Partners Brian Bares, Russell Mollen, And James Bradshaw | 4,126,808 | $60,251,000 | +20% | 18.75% |
| 4. | Renaissance Technologies Jim Simons | 2,150,239 | $31,393,489 | -25% | 0.04% |
| 5. | Portolan Capital Management George Mccabe | 1,932,514 | $28,214,704 | -12% | 1.06% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.39 | 139,713 | $2,149,638.19 | 790,548 | 2026-08-12 | Filing | |
| $16.07 | 411 | $6,603.87 | 439,690 | 2026-08-12 | Filing | |
| $16.07 | 230 | $3,695.59 | 141,802 | 2026-08-12 | Filing | |
| $16.38 | 41,734 | $683,419.29 | 334,219 | 2026-07-08 | Filing | |
| $15.76 | 103,188 | $1,625,892.04 | 590,777 | 2026-07-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,861,007 | $202,370,702 | 89.61% | |
| 2. | 6,181,269 | $90,240,208 | 0.62% | |
| 3. | 5,971,666 | $87,186,318 | 0% | |
| 4. | 5,684,040 | $82,986,980 | 0% | |
| 5. | 3,266,753 | $47,694,594 | 0.08% |
News See All
Is Cellebrite DI Ltd. (CLBT) A Good Stock To Buy Now?
Is CLBT a good stock to buy? We came across a bullish thesis on Cellebrite DI Ltd. on InfoArb Sheets’s Substack. In this article, we will summarize the bulls’ thesis on CLBT.
10 Stocks Under $20 That Will Explode
According to a June 9, 2026, Reuters report, world markets have swung sharply over the past week, reflecting heightened uncertainty about the economic outlook.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q1 2026 Earnings Call Transcript
Operator: Welcome to the Cellebrite First Quarter 2026 Financial Results Conference Call. [Operator Instructions]. I would now like to turn the call over to your first speaker today, Mr.
Is Cellebrite DI Ltd. (CLBT) A Good Stock To Buy Now?
Is CLBT a good stock to buy? We came across a bullish thesis on Cellebrite DI Ltd. on Danny’s Substack by Danny Green. In this article, we will summarize the bulls’ thesis on CLBT.
10 Best Cybersecurity Stocks to Invest in According to Analysts
In this article, we will look at some of the best names in the cybersecurity space that currently offer attractive upside for investors.
10 Tech Stocks to Sell Right Now According to Cathie Wood
Technology stocks have been on the back foot, having experienced a significant sell-off in the first quarter of 2026.
10 Best NASDAQ Stocks Under $30 to Buy
On March 9, Allan Small, Senior Investment Advisor for Allan Small Financial Group at iA Private Wealth, appeared on BNN Bloomberg to discuss the extreme volatility of oil prices and the resulting investment...
Artisan Small Cap Fund Picked Cellebrite (CLBT) Following New Product Cycle Analysis
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap Fund”. A copy of the letter can be downloaded here.
What Gives Cellebrite DI Ltd. (CLBT) a Competitive Moat?
Voss Capital, LLC, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Hedge Fund Resource Center